Hualan Biological Engineering Inc
SZSE:002007
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hualan Biological Engineering Inc
SZSE:002007
|
CN |
|
Z
|
Zedge Inc
AMEX:ZDGE
|
US |
|
CK Infrastructure Holdings Ltd
HKEX:1038
|
HK |
|
Security Matters Ltd
ASX:SMX
|
AU |
|
I
|
IT Tech Packaging Inc
AMEX:ITP
|
CN |
|
S
|
Samfine Creation Holdings Group Ltd
NASDAQ:SFHG
|
HK |
|
Nanoco Group PLC
LSE:NANO
|
UK |
|
Blackstone Secured Lending Fund
F:GM8
|
US |
Wall Street
Price Targets
Price Targets Summary
Hualan Biological Engineering Inc
According to Wall Street analysts, the average 1-year price target for
Hualan Biological Engineering Inc
is 20.16 CNY
with a low forecast of 18.18 CNY and a high forecast of 24.47 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Hualan Biological Engineering Inc's stock price target?
Price Target
20.16
CNY
According to Wall Street analysts, the average 1-year price target for
Hualan Biological Engineering Inc
is 20.16 CNY
with a low forecast of 18.18 CNY and a high forecast of 24.47 CNY.
What is Hualan Biological Engineering Inc's Revenue forecast?
Projected CAGR
17%
For the last 14 years the
compound annual growth rate for
Hualan Biological Engineering Inc's revenue is
12%.
The projected
CAGR
for the next 2 years is
17%.
What is Hualan Biological Engineering Inc's Operating Income forecast?
Projected CAGR
26%
For the last 14 years the
compound annual growth rate for
Hualan Biological Engineering Inc's operating income is
8%.
The projected
CAGR
for the next 3 years is
26%.
What is Hualan Biological Engineering Inc's Net Income forecast?
Projected CAGR
34%
For the last 14 years the
compound annual growth rate for
Hualan Biological Engineering Inc's net income is
7%.
The projected
CAGR
for the next 2 years is
34%.
